Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

NIOSHTIC-2 Publications Search

Search Results

Cooperativity between oxidants and tumor necrosis factor in the activation of nuclear factor (NF)-kappaB: requirement of Ras/mitogen-activated protein kinases in the activation of NF-kappaB by oxidants.

Authors
Janssen-Heininger-YM; Macara-I; Mossman-BT
Source
Am J Respir Cell Mol Biol 1999 May; 20(5):942-952
NIOSHTIC No.
20030046
Abstract
The transcription factor nuclear factor (NF)-kappaB is activated by oxidative stress or cytokines and is critical to the activation of inflammatory genes. Here, we report that hydrogen peroxide or 3-morpholinosydnonimine, which simultaneously releases nitric oxide and superoxide, synergize with the cytokine tumor necrosis factor (TNF)-alpha to activate NF-kappaB in rat lung epithelial cells, suggesting that signaling pathways elicited by reactive oxygen species (ROS)/reactive nitrogen species (RNS) are different from TNF-induced signaling. These findings were substantiated by observations that levels of IkappaB-alpha did not change after exposure to ROS/RNS, whereas a rapid depletion of IkappaB-alpha was observed in cells exposed to TNF. In addition, the proteosome inhibitor MG132 did not affect activation of NF-kappaB by ROS/RNS, whereas it abolished the TNF response. Transfection of a dominant negative Ras construct prevented the activation of NF-kappaB by ROS/RNS, demonstrating the requirement for Ras in the activation of NF-kappaB by oxidants. In contrast, TNF activated NF-kappaB in a Ras-independent fashion. Evaluation of members of the mitogen-activated protein kinase (MAPK) family as downstream effectors of Ras revealed the requirement of MAPK/ extracellular-regulated kinase (ERK) kinase kinase (MEKK)1 and c-Jun N-terminal kinases in the induction of NF-kappaB by both oxidants and TNF, whereas the MEK-ERK pathway negatively regulates NF-kappaB. Our findings demonstrate that cytokines and oxidants cooperate in the activation of transcription factors through distinct pathways, and suggest that anti-inflammatory and antioxidant therapies may be required in concert to prevent the activation of NF-kappaB-regulated genes important in the development of inflammatory diseases.
Keywords
Pulmonary-system-disorders; Proteins; Inhalation-studies; Lung-cells; Nucleic-acids; Inhalation-studies; Bioactivation; Immunochemistry
Contact
Department of Pathology, University of Vermont Medical Alumni Building, Burlington, Vermont; and The Center for Cell Signaling, University of Virginia, Charlottesville, Virginia
CODEN
AJRBEL
CAS No.
1332-21-4; 12001-29-5; 12001-28-4
Publication Date
19990501
Document Type
Journal Article
Funding Amount
75969
Funding Type
Grant
Fiscal Year
1999
NTIS Accession No.
NTIS Price
Identifying No.
Grant-Number-R03-OH-03467
Issue of Publication
5
ISSN
1044-1549
Source Name
American Journal of Respiratory Cell and Molecular Biology
State
VT
Performing Organization
Pathology University of Vermont Medical Alumni Bldg a 249 Burlington, VT 05405-0068
TOP